LigaChem Biosciences is a clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. The company specializes in the discovery and development of novel therapeutics utilizing proprietary technology platforms such as antibody-drug conjugates. With decades of dedicated drug development experience, it drives global healthcare innovation through open collaboration.
Subscribe to see LigaChem’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
LigaChem is a biotechnology company headquartered in South Korea. Its most recent funding round, Growth, raised $323M in June 2026. Xcout tracks 6 named people at LigaChem, including 한진환 (CTO 전무).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $323M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.